Mitochondrial Dysfunction: A Unifying Presence in Mental Illness

For decades, psychiatry and psychology have approached mental illness through the lens of chemical imbalances in the brain. We prescribe selective serotonin reuptake inhibitors for depression, medications that block dopamine for psychosis, and mood stabilisers for bipolar disorder. Whilst these interventions provide symptom relief for many patients, they rarely address the fundamental question: why do these brain chemical systems fail in the first place? A growing body of research suggests that diverse psychiatric presentations, from schizophrenia to depression to ADHD, may share a common underlying cause: mitochondrial dysfunction.

The Brain's Energy Crisis

Dr Christopher Palmer, a psychiatrist at Harvard Medical School and McLean Hospital, has spent nearly three decades treating people experiencing severe mental health conditions. His 2022 book Brain Energy proposes a paradigm shift in psychiatric understanding: mental disorders are fundamentally metabolic disorders of the brain. This assertion challenges conventional thinking, yet it rests on decades of neuroscience, metabolic research, and clinical observation.

The brain represents only two per cent of body mass yet consumes approximately twenty per cent of the body's total energy. This extraordinary demand makes the brain uniquely vulnerable to disruptions in cellular energy production. Within each brain cell, hundreds to thousands of mitochondria work continuously to transform nutrients and oxygen into ATP, the molecular fuel that powers every cellular process. When mitochondrial function falters, the consequences cascade throughout the brain's complex circuitry.

Dr Palmer's theory brings together biological, psychological, and social risk factors under a single metabolic framework. Genetics, trauma, inflammation, stress, substance use, and nutritional factors all influence mitochondrial function through various mechanisms. The theory explains why mental illness often co-occurs with metabolic conditions such as obesity, diabetes, and cardiovascular disease. These conditions share common underlying problems rooted in how cells produce and use energy.

Evidence from Mitochondrial Medicine

Dr Douglas Wallace, founder of the field of mitochondrial genetics, has been investigating the role of mitochondria in disease for decades. Dr Wallace states that all psychiatric disorders may result from mitochondrial dysfunction.

Dr Wallace's research has shown that the mitochondrial genome encompasses over a thousand genes in the cell nucleus plus hundreds to thousands of copies of maternally inherited mitochondrial DNA. Problems in either set of genes, or combinations of the two, can be sufficient to cause psychiatric and neurological disorders. His research has identified inherited and acquired mitochondrial DNA mutations associated with autism spectrum disorder, schizophrenia, bipolar disorder, and major depressive disorder.

The evidence supporting mitochondrial involvement in psychiatric conditions extends beyond genetic studies. Brain tissue examined after death from people who experienced schizophrenia, bipolar disorder, and major depression consistently shows signs of mitochondrial dysfunction, including reduced enzyme activity in the energy production system, increased oxidative damage, and altered mitochondrial structure. These findings appear in medication-naïve individuals and persist across diverse psychiatric presentations.

Metabolic Burden in Severe Mental Illness

The connection between metabolic dysfunction and mental illness has significant implications for public health. In the UK, more than 800,000 people live with severe mental illness, including conditions such as schizophrenia, severe depression, and bipolar disorder. Research published by Dr Nicole Needham, Dr Iain Campbell, and colleagues highlights the sobering reality: people experiencing severe mental illness have a life expectancy on average ten to twenty years shorter than the general population. In the UK, over seventy per cent of deaths among those with severe mental illness are due to preventable physical illnesses, with metabolic dysfunction and cardiovascular disease accounting for a significant proportion.

Why Different Diagnoses from Similar Pathology?

One compelling aspect of the mitochondrial theory is its capacity to explain diagnostic heterogeneity. If mitochondrial dysfunction represents the core problem, why does one individual experience schizophrenia whilst another experiences ADHD or depression? The answer lies in which brain regions and cell populations are most affected.

Different brain areas have vastly different energy demands. Brain cells in the prefrontal cortex, which supports executive function, require enormous energy to maintain their complex branching structures and extensive connections with other cells. When these energy-intensive cells are metabolically compromised, the clinical picture looks like impaired decision-making, reduced working memory, and diminished emotional regulation. These symptoms overlap substantially across diagnostic categories.

Dr Martin Picard, associate professor of behavioural medicine in psychiatry and neurology at Columbia University, has pioneered the field of mitochondrial psychobiology. His work mapping mitochondrial diversity across the human brain reveals that more recently evolved areas of the cortex contain more energy-specialised mitochondria than older brain structures. This finding helps explain why higher cognitive functions are particularly vulnerable to metabolic disruption.

Dr Picard's research team has also demonstrated that distinct brain cell types possess different mitochondrial profiles with varying characteristics. Excitatory neurones, inhibitory neurones, support cells called astrocytes, immune cells called microglia, and insulating cells called oligodendrocytes each have unique mitochondrial features adapted to their specific functions. When metabolic stress affects the brain, the clinical presentation depends on which cell types and brain regions bear the greatest burden. This explains why similar mitochondrial dysfunction can produce markedly different symptom profiles.

Mitochondria Beyond Energy Production

Calling mitochondria the "powerhouses of the cell" dramatically underestimates their role in health and disease. As Dr Picard emphasises, mitochondria function more like the "CEO’s” of the cell, taking in information from multiple sources and directing cellular responses.

Mitochondria produce all circulating steroid hormones, including cortisol, oestrogen, testosterone, and progesterone. When mitochondrial function becomes disrupted, hormone production follows suit, contributing to the hormone abnormalities commonly observed in psychiatric conditions. Problems with the stress hormone system characteristic of depression, the elevated cortisol associated with chronic stress, and the reproductive hormone irregularities seen in some people living with schizophrenia may all reflect upstream mitochondrial dysfunction.

Mitochondria also regulate calcium balance, cell death signals, and the production of molecules that can damage cells when produced in excess. They control the expression of more than two thirds of genes in the cell nucleus, fundamentally shaping how cells develop and function. Dysfunctional mitochondria send incorrect signals that alter which genes are turned on or off, inflammatory responses, and how resilient cells are to stress.

The Mitochondrial Life Cycle and Psychiatric Risk

Mitochondria continuously undergo division, fusion, and selective removal when damaged. These processes, collectively termed mitochondrial dynamics, are essential for maintaining a healthy mitochondrial population.

Chronic stress, inflammation, and other risk factors for mental illness impair these processes. Dr Picard's research on psychological stress and mitochondria demonstrates that acute and chronic stressors influence mitochondrial function, particularly within the brain. His systematic review of preclinical studies found that nineteen out of twenty-three investigations showed significant harmful effects of psychological stress on mitochondrial function.

The concept of "mitochondrial allostatic load" describes the collective burden of stress-induced mitochondrial changes. Just as allostatic load refers to the wear and tear on body systems from chronic stress, mitochondrial allostatic load represents the progressive deterioration of mitochondrial function under sustained psychological or physical challenge. This framework helps explain why early life adversity, chronic trauma, and persistent social stress increase psychiatric vulnerability by degrading the cellular machinery required for optimal brain function.

Clinical Implications and Treatment Strategies

The mitochondrial theory of mental illness carries profound implications for treatment. If psychiatric symptoms arise from cellular energy failure, interventions that enhance mitochondrial function should prove therapeutic. This prediction has been borne out in clinical practice and emerging research.

Ketogenic metabolic therapy has emerged as a promising intervention for psychiatric conditions. Originally developed in 1921 to control seizures in children with intractable epilepsy, ketogenic diets have demonstrated their ability to stabilise neuronal networks through more than a dozen randomised controlled trials. Given the significant overlapping pathophysiology between epilepsy and bipolar disorder and given that many of the same medications treat both conditions, researchers hypothesised that ketogenic diets might offer mood stabilising properties. A rapidly growing body of clinical research now points to potential benefits across a wide variety of psychiatric conditions.

Ketogenic diets are very low in carbohydrate, moderate in protein, and relatively high in fat. This diet lowers and stabilises glucose levels whilst reducing insulin to the fat-burning point, generating ketones which cross the blood-brain barrier and serve as a supplemental fuel source for neurones. These metabolic effects can help address neuroinflammation and oxidative stress, neurotransmitter dysregulation, mitochondrial dysfunction, and other abnormalities commonly observed across a spectrum of chronic diseases affecting the central nervous system.

Recent pilot studies have produced encouraging results. In 2022, Dr Albert Danan and Dr Georgia Ede published a retrospective analysis of thirty-one adults with chronic, treatment-resistant major depression, bipolar disorder, or schizophrenia who added a whole-foods ketogenic diet to their treatment regimen in a semi-controlled inpatient setting. All twenty-eight participants who adhered to the diet improved substantially, with forty-three per cent achieving clinical remission from their primary psychiatric diagnosis and sixty-four per cent discharged on less psychiatric medication.

In 2024, Dr Shebani Sethi and colleagues at Stanford University published an uncontrolled pilot study finding that seventy-nine per cent of adult participants with bipolar disorder or schizophrenia experienced clinically meaningful improvement in their symptoms in response to a ketogenic diet added to usual treatment. Research teams at the University of Edinburgh and Ohio State University have published similar findings in bipolar disorder and major depression respectively, with participants showing substantial symptom reduction and improved metabolic health markers.

Equally promising results have emerged from Ohio State University, where Dr Drew Decker and colleagues published findings in 2025 demonstrating remarkable improvements in students experiencing major depression. In this uncontrolled pilot study, one hundred percent of students who adhered to a ketogenic diet as an addition to their pre-existing treatments showed improvement, with participants averaging a sixty-nine percent reduction in symptom scores.

Right now, at James Cook University in Townsville, a large-scale randomised controlled trial is currently underway. Led by Professor Zoltan Sarnyai and Associate Professor Calogero Longhitano, this study is examining the effects of ketogenic metabolic therapy on both mental and metabolic health in people living with schizophrenia and bipolar disorder.

More than two dozen new studies, including some large randomised controlled clinical trials, are currently exploring the effects of ketogenic diets in conditions including autism, ADHD, anorexia nervosa, major depression, post-traumatic stress disorder, bipolar disorder, schizophrenia, paediatric mood disorders, and Alzheimer's disease. These trials are being conducted at research centres around the world, supported by organisations including the Baszucki Group, a philanthropic initiative dedicated to transforming mental health outcomes through metabolic approaches.

Exercise represents another powerful mitochondrial intervention. Resistance training and moderate-intensity aerobic exercise stimulate the growth of new mitochondria, enhance their capacity to produce energy, and improve how efficiently they work. The well-documented psychiatric benefits of exercise may reflect these fundamental mitochondrial effects.

Sleep is critical for mitochondrial health. During sleep, damaged mitochondrial components undergo repair and dysfunctional mitochondria are cleared out. Chronic sleep deprivation, a common feature of psychiatric illness, impairs these essential maintenance processes, creating a vicious cycle of declining mitochondrial function and worsening symptoms.

Reducing toxic exposures represents another therapeutic avenue. Alcohol, recreational drugs, and certain medications impair mitochondrial function. Some psychiatric medications, particularly certain antipsychotics and mood stabilisers, can negatively affect mitochondrial function and metabolic health. This creates a clinical paradox where treatments that provide short-term symptom relief may compromise long-term metabolic health. Carefully supervised medication optimisation, guided by metabolic as well as psychiatric outcomes, becomes essential.

The Path Forward

The mitochondrial framework for understanding mental illness provides a biological mechanism through which psychological, social, and environmental factors converge to affect brain function. Trauma alters which mitochondrial genes are turned on or off, social isolation impairs how mitochondria function and communicate, nutritional deficiencies compromise the enzymes mitochondria need to work properly, and chronic stress progressively damages mitochondrial function.

Traditional genetic models have struggled to explain common metabolic and degenerative diseases because these conditions primarily reflect problems with how cells produce energy. The genes most critical for cellular energy production reside in the mitochondria themselves, which follow different inheritance patterns and change more rapidly than genes in the cell nucleus. Mitochondria are inherited exclusively from mothers, which helps explain why some psychiatric conditions show patterns of transmission through the maternal line whilst also explaining why people with similar genetic backgrounds can show such different symptoms.

We are witnessing the emergence of metabolic psychiatry as a field that combines population studies, basic science research, and clinical investigations to understand the role of metabolism in mental illness. Major research hubs have been established in the UK, United States, and Australia, bringing together researchers dedicated to accelerating our understanding of severe mental illness. This represents a return to first principles in medicine, recognising that all cellular processes, including producing brain chemicals, transmitting signals between nerve cells, and the brain's ability to change and adapt, depend fundamentally on adequate energy supply.

The implications extend beyond individual patient care to public health and prevention. If mitochondrial dysfunction represents a common pathway in mental illness, supporting mitochondrial health across the lifespan may reduce psychiatric incidence. Good nutrition during pregnancy and childhood, avoiding toxins, staying physically active, getting adequate sleep, and managing stress all become ways to prevent mental illness, not just treat it.

For people who have found limited benefit from conventional psychiatric approaches, the mitochondrial framework offers new hope. By addressing the cellular and metabolic foundations of brain function, we can support genuine recovery. Combining metabolic interventions with evidence-based psychotherapy, judicious medication use when needed, and comprehensive lifestyle changes provides a path towards sustained mental health that treats the whole person.

The work of clinicians and researchers around the world is illuminating what has been hiding in plain sight for decades. Mental illness reflects brain energy failure. By supporting the mitochondria that power every thought, emotion, and behaviour, we can transform psychiatric care into a field capable of facilitating true healing.

References

Campbell, I. H., & Campbell, H. (2024). The metabolic overdrive hypothesis: Hyperglycolysis and glutaminolysis in bipolar mania. Molecular Psychiatry, 29, 1521-1527. doi:10.1038/s41380-024-02431-w

Decker, D. D., Patel, R., Cheavens, J., Hayes, S. M., Whitted, W., Lee, A. J., Buga, A., Robinson, B. T., Crabtree, C. D., Kackley, M. L., Stoner, J. T., Sapper, T. N., Chebbi, A., & Volek, J. S. (2025). A pilot study examining a ketogenic diet as an adjunct therapy in college students with major depressive disorder. Translational Psychiatry, 15(1), 322. https://doi.org/10.1038/s41398-025-03544-8

Longhitano, C., Finlay, S., Peachey, I., Swift, J.-L., Fayet-Moore, F., Bartle, T., Vos, G., Rudd, D., Shareef, O., Gordon, S., Azghadi, M. R., Campbell, I., Sethi, S., Palmer, C., & Sarnyai, Z. (2024). The effects of ketogenic metabolic therapy on mental health and metabolic outcomes in schizophrenia and bipolar disorder: a randomised controlled clinical trial protocol. Frontiers in Nutrition, 11, 1444483. https://doi.org/10.3389/fnut.2024.1444483

Needham, N., Campbell, I. H., Grossi, H., Kamenska, I., Rigby, B. P., Simpson, S. A., . . . Smith, D. J. (2023). Pilot study of a ketogenic diet in bipolar disorder. BJPsych Open, 9, e176. doi:10.1192/bjo.2023.568

Needham, N., Kamenská, I., Meadowcroft, B., Brown, R., & Grossi, H. (2025). Metabolic dysfunction in severe mental illness: Updates on prevalence, aetiology and treatment options. BJPsych Advances, 31(4), 201-210. doi:10.1192/bja.2024.52

Palmer, C. (2022). Brain energy: A revolutionary breakthrough in understanding mental health and improving treatment for anxiety, depression, OCD, PTSD, and more. Dallas, TX: BenBella Books.

Pei, L., & Wallace, D. C. (2018). Mitochondrial etiology of neuropsychiatric disorders. Biological Psychiatry, 83(9), 722-730. doi:10.1016/j.biopsych.2017.11.018

Picard, M., & McEwen, B. S. (2018a). Psychological stress and mitochondria: A conceptual framework. Psychosomatic Medicine, 80(2), 126-140. doi:10.1097/PSY.0000000000000544

Picard, M., & McEwen, B. S. (2018b). Psychological stress and mitochondria: A systematic review. Psychosomatic Medicine, 80(2), 141-153. doi:10.1097/PSY.0000000000000545

Picard, M., & Sandi, C. (2021). The social nature of mitochondria: Implications for human health. Neuroscience & Biobehavioral Reviews, 120, 595-610. doi:10.1016/j.neubiorev.2020.11.017

Wallace, D. C. (2013). A mitochondrial bioenergetic etiology of disease. Journal of Clinical Investigation, 123(3), 1405-1412. doi:10.1172/JCI61398

Wallace, D. C. (2017). A mitochondrial etiology of neuropsychiatric disorders. JAMA Psychiatry, 74(9), 863-864. doi:10.1001/jamapsychiatry.2017.0397